scholarly journals Increased resistance to nitrogen mustards and antifolates following in vitro selection of murine fibroblasts and primary hematopoietic cells transduced with a bicistronic retroviral vector expressing the rat glutathione S-transferase A3 and a mutant dihydrofolate reductase

2003 ◽  
Vol 10 (8) ◽  
pp. 637-646 ◽  
Author(s):  
Jean-Philippe Belzile ◽  
Antonis Karatzas ◽  
Hoi-Ying Shiu ◽  
Sylvain Létourneau ◽  
Jean-Sébastien Palerme ◽  
...  
2008 ◽  
Vol 13 (6) ◽  
pp. 504-514 ◽  
Author(s):  
Elena Fossati ◽  
Jordan P. Volpato ◽  
Lucie Poulin ◽  
Vanessa Guerrero ◽  
David-Antoine Dugas ◽  
...  

We report a rapid and reliable 2-tier selection and screen for detection of activity as well as drug-resistance in mutated variants of a clinically-relevant drug-target enzyme. Human dihydrofolate reductase point-mutant libraries were subjected to a 1st-tier bacterial complementation assay, such that bacterial propagation served as an indicator of enzyme activity. Alternatively, when selection was performed in the presence of the inhibitor methotrexate (MTX), propagation indicated MTX resistance. The selected variants were then subjected to a 2nd-tier in vitro screen in 96-well plate format using crude bacterial lysate. Conditions were defined to establish a threshold for activity or for MTX resistance. The 2nd-tier assay allowed rapid detection of the best variants among the leads and provided reliable estimates of relative reactivity, ( kcat) and IC50MTX. Screening saturation libraries of active-site positions 7, 15, 24, 70, and 115 revealed a variety of novel mutations compatible with reactivity as well as 2 novel MTX-resistant variants: V115A and V115C. Both variants displayed KiMTX = 20 nM, a 600-fold increase relative to the wild-type. We also present preliminary results from screening against further antifolates following simple modifications of the protocol. The flexibility and robustness of this method will provide new insights into interactions between ligands and active-site residues of this clinically relevant human enzyme. ( Journal of Biomolecular Screening 2008:504-514)


Blood ◽  
2004 ◽  
Vol 104 (11) ◽  
pp. 5270-5270
Author(s):  
Michael Flasshove ◽  
Ina Rattmann ◽  
Kai Lehmberg ◽  
Walter Bardenheuer ◽  
Ursula R. Sorg ◽  
...  

Abstract Retroviral gene transfer of human cytidine deaminase into murine hematopoietic cells has been shown to confer drug resistance against cytidine analogues such as araC (1-β-D-arabinofuranosylcytosine) and gemcitabine (2′,2′-difluorodeoxycytidine). Since data for primary human hematopoietic cells are lacking so far, we transduced human CD34+ enriched umbilical cord blood cells with the retroviral vector SF91-CDD-IRES-EGFP containing the cDNA of cytidine deaminase (CDD) and EGFP as a reporter gene. The transduced cells were tested in clonogenic assays for resistance against increasing concentrations of araC or gemcitabine. Gene transfer of SF91-CDD-IRES-EGFP resulted in a transduction efficiency of 28 ± 2% (n = 4). A significant higher survival of CFU-C in the presence of araC could be demonstrated as compared with the mock control expressing EGFP only. This protective effect was improved by FACS enrichment of EGFP+ cells prior to functional analysis, and was observed for a dose range of 30 – 500 nM araC. Gemcitabine resistance was also tested with cells enriched for EGFP expression. For CFU-C a significant higher survival of colonies at concentrations of 8 and 10nM could be shown. This protection was more pronounced for CFU-GM than for BFU-E. The IC50 value increased 3fold for CFU-GM but only 1.4fold for BFU-E and 1.8fold for total CFU-C in comparison to the mock control (n = 4). In vitro selection of CDD transduced progenitor cells was investigated by incubation in the presence of 30 – 100nM araC for 4 or 8 days. Before and after culture cells were analysed for EGFP expression and tested in clonogenic assays for araC resistance. Significant selection of CDD transduced cells as measured by EGFP expression was observed for all examined concentrations. After 4 days incubation with 60nM araC clonogenic assays revealed a significant selection of progenitor cells resistant to 100 – 500nM araC. Incubation of transduced cells in 6 – 15nM gemcitabine for 4 or 8 days likewise allowed successful in vitro selection. Transplantation of CDD transduced CD34+ cells in sublethally irradiated NOD/SCID mice resulted in up to 81% engraftment of human CD45+ cells and a rate of up to 4.6% of human CD45+/EGFP+ cells after 8 weeks. These data demonstrate that retroviral gene transfer of CDD protects human hematopoietic cells from the cytotoxic drugs araC and gemcitabine and allows selection of transduced cells. Successful engraftment of CDD transduced cells in NOD/SCID repopulating cells could be observed.


2020 ◽  
Vol 65 (9-10) ◽  
pp. 3-7
Author(s):  
V. V. Gostev ◽  
Yu. V. Sopova ◽  
O. S. Kalinogorskaya ◽  
M. E. Velizhanina ◽  
I. V. Lazareva ◽  
...  

Glycopeptides are the basis of the treatment of infections caused by MRSA (Methicillin-Resistant Staphylococcus aureus). Previously, it was demonstrated that antibiotic tolerant phenotypes are formed during selection of resistance under the influence of high concentrations of antibiotics. The present study uses a similar in vitro selection model with vancomycin. Clinical isolates of MRSA belonging to genetic lines ST8 and ST239, as well as the MSSA (ATCC29213) strain, were included in the experiment. Test isolates were incubated for five hours in a medium with a high concentration of vancomycin (50 μg/ml). Test cultures were grown on the medium without antibiotic for 18 hours after each exposure. A total of ten exposure cycles were performed. Vancomycin was characterized by bacteriostatic action; the proportion of surviving cells after exposure was 70–100%. After selection, there was a slight increase in the MIC to vancomycin (MIC 2 μg/ml), teicoplanin (MIC 1.5–3 μg/ml) and daptomycin (MIC 0.25–2 μg/ml). According to the results of PAP analysis, all strains showed an increase in the area under curve depending on the concentration of vancomycin after selection, while a heteroresistant phenotype (with PAP/AUC 0.9) was detected in three isolates. All isolates showed walK mutations (T188S, D235N, E261V, V380I, and G223D). Exposure to short-term shock concentrations of vancomycin promotes the formation of heteroresistance in both MRSA and MSSA. Formation of VISA phenotypes is possible during therapy with vancomycin.


2002 ◽  
Vol 5 (6) ◽  
pp. 473-480
Author(s):  
Bentham Science Publisher A.N. Alexandrov ◽  
Bentham Science Publisher V.Yu. Alakhov ◽  
Bentham Science Publisher A.I. Miroshnikov

2000 ◽  
Vol 15 (4) ◽  
pp. 297-308 ◽  
Author(s):  
NAOZUMI TERAMOTO ◽  
YUKIO IMANISHI ◽  
YOSHIHIRO ITO

2020 ◽  
Vol 59 (20) ◽  
pp. 7968-7968
Author(s):  
Meng Liu ◽  
Jiayi Wang ◽  
Yangyang Chang ◽  
Qiang Zhang ◽  
Dingran Chang ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document